Search
for
Sort by
Research 361–390 of 397
- Southern African HIV Clinicians Society gender-affirming healthcare guideline for South Africa
- Genetic and other epidemiological risk factors of infants and children with hypospadias: a case control study
- Dermatopathia pigmentosa reticularis: A report of a case with delayed onset alopecia and onychodystrophy
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
- Lasers, lights, and compounds for hair loss in aesthetics
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- The Men’s Training Cup Keep Training: a masturbation aid improves intravaginal ejaculatory latency time and Erection Hardness Score in patients who are unable to delay ejaculation
- Hair thread tourniquet syndrome in a male infant: a rare surgical emergency
- Transforming By-Products into Functional Resources: The Potential of Cucurbitaceae Family Seeds in Cosmetics
- The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the BSCL2 Gene: Results From the First-year
- Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients
- Post-finasteride syndrome - a true clinical entity?
- Bicalutamide: A review
- Dermatological care of gender‐diverse patients in Australia
- High-Dose Vitamin D3 and Tonsillectomy as Therapeutic Management in Henoch-Schönlein Purpura Following Hepatitis B Vaccination: A Rare Case Report.
- Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells
- Evaluating the psychosocial impact of gender‐affirming dermatology treatments: A systematic review
- Comment on Current Investigations into the Postfinasteride Syndrome
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Therapeutic potential of adult platelets and cord blood platelets in future clinical directions
- Tourniquet syndrome in children (literature review and own observation)
- Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency